Wordt geladen...
Perspectives of U.S. Private Payers on Insurance Coverage for Pediatric and Prenatal Exome Sequencing – Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS)
PURPOSE: Exome sequencing (ES) has the potential to improve management of congenital anomalies and neurodevelopmental disorders in fetuses, infants and children. U.S. payers are key stakeholders in patient access to ES. We examined how payers view insurance coverage and clinical utility of pediatric...
Bewaard in:
| Gepubliceerd in: | Genet Med |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7004856/ https://ncbi.nlm.nih.gov/pubmed/31501586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41436-019-0650-7 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|